Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DREVAC pneumococcal vaccination study
2010-023971-25Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of pneumococcal 13-valent conjugate vaccine and Pneumo 23 in pneumococcal disease, sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2019; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccinePneumo 23
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2010-023971-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023971-25.